Upload
arif-alamgir
View
228
Download
0
Embed Size (px)
Citation preview
8/19/2019 Presentation of Beximco Pharmaceuticals
1/22
PresentationPresentation
ononAnalysis ofAnalysis of
Dividend policy & Capital structureDividend policy & Capital structure
8/19/2019 Presentation of Beximco Pharmaceuticals
2/22
8/19/2019 Presentation of Beximco Pharmaceuticals
3/22
Overview of company• Beximco Parma is a leading edge parmaceuticalcompany based in Da!a" Banglades#
• Beximco Parma acclaimed for its outstanding
product $uality" world%class manufacturingfacilities" product development capabilities andoutstanding professional services#
• Beximco Parma is also te largest exporter ofparmaceutical products from Banglades andreceived ational 'xport (ropy )*old+" teigest national accolade for export" for recordtree times#
8/19/2019 Presentation of Beximco Pharmaceuticals
4/22
Overview of company• ,-./0 1egistration of te company#• ,-230 4auncing of its own brands#
• ,-250 4isting in te Da!a 6toc! 'xcange )D6'+
• ,--70 6tarted export operation wit ActiveParmaceutical 8ngredients )AP8s+#
• ,--20 9irst parmaceutical company of tecountry acieving :ational 'xport (ropy )*old+:for ,--;%-5
8/19/2019 Presentation of Beximco Pharmaceuticals
5/22
'arning Per 6are
8/19/2019 Presentation of Beximco Pharmaceuticals
6/22
Mar!et price per sare
8/19/2019 Presentation of Beximco Pharmaceuticals
7/22
Price 'arning 1atio
8/19/2019 Presentation of Beximco Pharmaceuticals
8/22
'P6 and Dividend of
company
8/19/2019 Presentation of Beximco Pharmaceuticals
9/22
Dividend policy
Beximco parma follow
lo/ re)ular etra diidend
oliy
8/19/2019 Presentation of Beximco Pharmaceuticals
10/22
Capital structure
Combination of different sources ofcapital
8/19/2019 Presentation of Beximco Pharmaceuticals
11/22
Capital
'$uitycapital
Debtcapital
8/19/2019 Presentation of Beximco Pharmaceuticals
12/22
Distribution of e$uity
8/19/2019 Presentation of Beximco Pharmaceuticals
13/22
Distribution of debt
8/19/2019 Presentation of Beximco Pharmaceuticals
14/22
Degree of operating
leverage
6ows relationsip between sales &'B8(
8/19/2019 Presentation of Beximco Pharmaceuticals
15/22
8/19/2019 Presentation of Beximco Pharmaceuticals
16/22
Degree of financial
leverage
6ows proportion of fixed financialobligation
8/19/2019 Presentation of Beximco Pharmaceuticals
17/22
8/19/2019 Presentation of Beximco Pharmaceuticals
18/22
Degree of total leverage
6ows relationsip between sales &'P6
8/19/2019 Presentation of Beximco Pharmaceuticals
19/22
8/19/2019 Presentation of Beximco Pharmaceuticals
20/22
8/19/2019 Presentation of Beximco Pharmaceuticals
21/22
D
8/19/2019 Presentation of Beximco Pharmaceuticals
22/22
After analy=ing it was found tat Beximcoparmaceuticals gave positive signal to tesareolders# Because tey ave
maintained teir dividend rate despitelower earnings and sales in 7>>.# Board ofdirectors as recommended ,>? stoc! and5? cas dividend% same as in prior year to
ensure better yield to ensure better yieldon te investment of valued sareolders#